These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12487009)

  • 21. 99mTc-MAG3: review of pharmacokinetics, clinical application to renal diseases and quantification of renal function.
    Itoh K
    Ann Nucl Med; 2001 Jun; 15(3):179-90. PubMed ID: 11545186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tc-99m MAG3 evaluation of recipients with dual adult cadaveric renal allografts. Simultaneous transplantation of both kidneys from marginal donors.
    Dunn EK; Distant DA; Strashun AM
    Clin Nucl Med; 1999 Aug; 24(8):547-52. PubMed ID: 10439172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefit of F-15 protocols in equivocal F + 20 MAG3 renography in children with upper tract dilatation and symmetric split function: Results and outcomes.
    Strasser C; Haid B; Langsteger W; Oswald J
    J Pediatr Urol; 2016 Oct; 12(5):295.e1-295.e6. PubMed ID: 27346069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of renal function from 99mTc-MAG3 renography without blood sampling.
    Inoue Y; Ohtake T; Yokoyama I; Yoshikawa K; Asai S; Ohtomo K
    J Nucl Med; 1999 May; 40(5):793-8. PubMed ID: 10319752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Usefulness of renal dynamic function study with 99mTc-MAG3 (mercaptoacetylglycylglycylglycine)].
    Shirakawa S; Tamaki N; Torizuka T; Fujita T; Yano S; Tsuchimochi S; Yonekura Y; Konishi J; Terai A
    Kaku Igaku; 1994 Aug; 31(8):977-83. PubMed ID: 7933686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical assessment of 99mTc-MAG3 scintigraphy for impaired renal function].
    Sato M; Hirayama K; Ishikawa N; Takeda T; Wu J; Itai Y; Kobayashi M; Koyama A
    Kaku Igaku; 1994 Jan; 31(1):75-84. PubMed ID: 8309113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive measurement of renal function with 99mTc-MAG3 gamma-camera renography based on the one-compartment model.
    Oriuchi N; Onishi Y; Kitamura H; Inoue T; Tomaru Y; Higuchi T; Inoue T; Endo K
    Clin Nephrol; 1998 Nov; 50(5):289-94. PubMed ID: 9840316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of early postoperative MAG3 renal scan to predict long-term outcomes of renal transplants.
    Park UJ; Kim HT; Cho WH; Kim MY; Hwang EA; Han SY; Park SB; Kim HC; Zeon SK
    Exp Clin Transplant; 2013 Apr; 11(2):118-21. PubMed ID: 23477352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and autoregulation of kidney function in children: a retrospective study using
    Cao X; Xu X; Treves ST; Drubach LA; Kwatra N; Zhang M; Fahey FH; Diamond DA; Voss SD
    Pediatr Nephrol; 2022 Sep; 37(9):2157-2166. PubMed ID: 35091836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal ranges of renal function parameters for 99mTc-EC renal scintigraphy.
    Danilczuk A; Nocun A; Chrapko B
    Nucl Med Rev Cent East Eur; 2020; 23(2):53-57. PubMed ID: 33007090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The reproducibility of measurements of differential renal function in paediatric 99mTc-MAG3 renography: is this correct?
    Sabour S; Ghassemi F
    Nucl Med Commun; 2012 Dec; 33(12):1311; author reply 1311-2. PubMed ID: 22972373
    [No Abstract]   [Full Text] [Related]  

  • 32. The half maximum time of (99m)Tc-DTPA renography measured in healthy kidney donors, compared to (131)I-OIH.
    Cheng B; Ding X; Du X; Xie X; Han X; Liu B
    Hell J Nucl Med; 2011; 14(3):322-3. PubMed ID: 22087462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of the normal range of furosemide half-clearance times when using Tc-99m MAG3.
    Rossleigh MA; Thomas MY; Moase AL
    Clin Nucl Med; 1994 Oct; 19(10):880-2. PubMed ID: 7805322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tc-99m MAG3 as an alternative to Tc-99m DTPA and I-131 Hippuran for renal transplant evaluation.
    O'Malley JP; Ziessman HA; Chantarapitak N
    Clin Nucl Med; 1993 Jan; 18(1):22-9. PubMed ID: 8422715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
    Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
    Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative 99mTc-MAG3 renal uptake: reproducibility and accuracy.
    Piepsz A; Tondeur M; Ham H
    J Nucl Med; 1999 Jun; 40(6):972-6. PubMed ID: 10452313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 99Tcm-MAG3 renogram deconvolution in normal subjects and in normal functioning kidney grafts.
    González A; Puchal R; Bajén MT; Mairal L; Prat L; Martin-Comin J
    Nucl Med Commun; 1994 Sep; 15(9):680-4. PubMed ID: 7816379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of renal function by calculation of fractional uptake of technetium-99m dimercaptosuccinic acid.
    Beatović SLj; Jaksić ED; Han RS
    Nucl Med Rev Cent East Eur; 2004; 7(1):49-52. PubMed ID: 15318311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential renal function estimation by dynamic renal scintigraphy: influence of background definition and radiopharmaceutical.
    Caglar M; Gedik GK; Karabulut E
    Nucl Med Commun; 2008 Nov; 29(11):1002-5. PubMed ID: 18836380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Background subtraction in technetium-99m-MAG3 renography.
    Taylor A; Thakore K; Folks R; Halkar R; Manatunga A
    J Nucl Med; 1997 Jan; 38(1):74-9. PubMed ID: 8998155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.